Clinical Trials in Myeloproliferative Disorders: Looking Forward
- 31 October 2005
- journal article
- review article
- Published by Elsevier BV in Seminars in Hematology
- Vol. 42 (4), 259-265
- https://doi.org/10.1053/j.seminhematol.2005.05.021
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational studyBlood, 2005
- Vascular and Neoplastic Risk in a Large Cohort of Patients With Polycythemia VeraJournal of Clinical Oncology, 2005
- Participation versus education: The GISSI story and beyondAmerican Heart Journal, 2004
- Efficacy and Safety of Low-Dose Aspirin in Polycythemia VeraNew England Journal of Medicine, 2004
- Chronic Myeloproliferative DisordersHematology-American Society Hematology Education Program, 2003
- Feasibility of Randomised Clinical Trials in Rare Diseases: The Case of Polycythemia VeraLeukemia & Lymphoma, 1996
- The very‐long‐term course of polycythaemia: a complement to the previously published data of the Polycythaemia Vera Study GroupBritish Journal of Haematology, 1994
- The Effects of Tissue Plasminogen Activator, Streptokinase, or Both on Coronary-Artery Patency, Ventricular Function, and Survival after Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionNew England Journal of Medicine, 1989
- Increased Incidence of Acute Leukemia in Polycythemia Vera Associated with Chlorambucil TherapyNew England Journal of Medicine, 1981